π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The study is being conducted to evaluate the efficacy, safety and tolerabil...
Status
Recruiting
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2025-06-08
Trial ID
NCT07026149
Treatments Being Tested
This study is a multicenter, randomized, uncontrolled clinical trial to eva...
Status
Active Not Recruiting
Location
Sichuan Cancer Hospital & Institute
Start Date
2024-11-21
Trial ID
NCT06693128
Treatments Being Tested
The study is being conducted to evaluate the efficacy, safety and tolerabil...
Status
Active Not Recruiting
Location
Affiliated Hospital of Hebei University
Start Date
2019-12-18
Trial ID
NCT04208347
Treatments Being Tested
This study was designed to evaluate the efficacy and safety of camrelizumab...
Status
Unknown
Location
The First Affiliated Hospital of Xi 'an Jiaotong University
Start Date
2021-01-01
Trial ID
NCT04792515
Treatments Being Tested
This is a study of Camrelizumab (SHR-1210) and Apatinb for unresectable Rec...
Status
Unknown
Location
Peking University Cancer Hospital
Start Date
2020-11-18
Trial ID
NCT04609176
Treatments Being Tested